Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discitis in Children: A 10-Year Retrospective Review in a Tertiary Pediatric Center.

Health science reports·2025
Same author

Translating metagenomics into clinical practice for complex paediatric neurological presentations.

The Journal of infection·2023
Same author

Case numbers of acute hepatitis of unknown aetiology among children in 24 countries up to 18 April 2022 compared to the previous 5 years.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2022
Same author

Immunogenicity and Efficacy of Pneumococcal Conjugate Vaccine (Prevenar13<sup>®</sup>) in Preventing Acquisition of Carriage of Pneumococcal Vaccine Serotypes in Tanzanian Children With HIV/AIDS.

Frontiers in immunology·2021
Same author

Promoting Breastfeeding and Interaction of Pediatric Associations With Providers of Nutritional Products.

Frontiers in pediatrics·2020
Same author

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study.

The Lancet. Child & adolescent health·2020
Same journal

Evaluating current bronchiectasis care in Italy according to the 2025 European respiratory society recommendations.

Therapeutic advances in respiratory disease·2026
Same journal

Decoding sarcoidosis chronicity through phenotypic profiling.

Therapeutic advances in respiratory disease·2026
Same journal

Impact of early therapeutic modality on 28-day mortality in immunocompromised patients with opportunistic pulmonary infections: a multicenter retrospective study.

Therapeutic advances in respiratory disease·2026
Same journal

Effects of dual bronchodilation on right ventricular function and troponin-I in newly diagnosed, moderate-to-severe chronic obstructive pulmonary disease: a prospective real-world observational study.

Therapeutic advances in respiratory disease·2026
Same journal

Diagnostic sensitivity and safety of visceral pleural biopsy under semi-rigid medical thoracoscopy in patients with undiagnosed exudative pleural effusions: a retrospective study.

Therapeutic advances in respiratory disease·2026
Same journal

Clinical, hemodynamic, and safety outcomes of sotatercept in pulmonary arterial hypertension: a meta-analysis of randomized trials with time-to-event data.

Therapeutic advances in respiratory disease·2026
See all related articles

Related Experiment Video

Updated: May 24, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Tuberculosis in childhood.

Delane Shingadia1

  • 1Department of Infectious Diseases, Great Ormond Street Hospital for Children, Great Ormond Street, London, UK. shingd@gosh.nhs.uk

Therapeutic Advances in Respiratory Disease
|February 25, 2012
PubMed
Summary
This summary is machine-generated.

Childhood tuberculosis (TB) is rising globally, often diagnosed using chest X-rays and skin tests with lower yields than in adults. New tests and standard multidrug treatments, including directly observed therapy, aim to improve outcomes for this critical public health issue.

Related Experiment Videos

Last Updated: May 24, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Area of Science:

  • Public Health
  • Infectious Diseases
  • Pediatrics

Background:

  • Global tuberculosis (TB) incidence is increasing, driven by factors like HIV and migration.
  • Childhood TB serves as an indicator of recent community transmission from infectious adults.
  • Current diagnostic methods for pediatric TB, including chest X-ray and tuberculin skin testing, have limitations in diagnostic yield compared to adults.

Purpose of the Study:

  • To review the current landscape of childhood tuberculosis diagnosis and treatment.
  • To highlight the challenges and advancements in managing TB in pediatric populations.
  • To emphasize the importance of early detection and effective treatment strategies for childhood TB.

Main Methods:

  • Review of existing literature on childhood tuberculosis diagnosis and treatment.
  • Analysis of diagnostic yield from traditional methods versus emerging technologies.
  • Examination of standard and alternative therapeutic regimens for pediatric TB.

Main Results:

  • Diagnostic yield for childhood TB is often suboptimal with conventional tests.
  • Newer diagnostic tools are under development to enhance accuracy in children.
  • Standard short-course multidrug treatment is widely adopted, with adherence being crucial for success.
  • Multidrug-resistant TB is an emerging concern in children, necessitating longer treatment with second-line drugs.

Conclusions:

  • Childhood TB requires tailored diagnostic and treatment approaches.
  • Advancements in diagnostics and adherence monitoring are vital for combating the resurgence of pediatric TB.
  • Addressing multidrug-resistant TB in children is a growing challenge requiring specialized interventions.